{"filings":[{"id":1100436,"accession_number":"0001213900-26-069512","cik":2079272,"company_name":"Lakewood-Amedex Biotherapeutics Inc.","ticker":"LABT","form_type":"8-K","filed_at":"2026-06-17T15:40:39+00:00","items":["3.03","5.03","9.01"],"status":"ready","headline":"Lakewood-Amedex announces 1-for-10 reverse stock split effective June 19, 2026","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse split ratio: 1-for-10; effective at 4:01 p.m. ET on June 19, 2026; trading starts split-adjusted on Nasdaq June 22.","Outstanding shares reduced from ~17,506,577 to ~1,750,789; fractional shares rounded up to next whole share.","Authorized shares reduced proportionately to 12,500,000; new CUSIP 51255A201 assigned; ticker LABT unchanged.","Board unanimously approved the split on June 1, 2026; adjustments made to equity awards, warrants, and preferred stock.","No stated reason for the split; typical use is to regain Nasdaq minimum bid price compliance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":4966782.989999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":97606,"accession_number":"0001213900-26-048553","cik":2079272,"company_name":"Lakewood-Amedex Biotherapeutics Inc.","ticker":"LABT","form_type":"8-K","filed_at":"2026-04-28T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Appoints Joseph Tucker to board; $6,000/quarter stock + 33,784 warrants at $10","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dr. Joseph Tucker appointed to Board, effective April 24, 2026, until 2027 annual meeting.","Compensation: $6,000 per quarter in common stock; granted 33,784 warrants at $10.00, 10-year term.","Warrants vest in 4 equal tranches: Oct 24, 2026; Apr 24, 2027; Oct 24, 2027; Apr 24, 2028.","Tucker is CEO of Enveric Biosciences (NASDAQ: ENVB) with over $100M capital raised track record.","Appointment follows LABT's recent Nasdaq direct listing; Tucker joins Audit, Compensation, Governance committees."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":4966782.989999999,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}